Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection

Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection

Bibliographic Details
Main Authors:	Wilson P. Lao, Sarah A. Imam, Shaun A. Nguyen
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2020-11-01
Series:	World Journal of Otorhinolaryngology-Head and Neck Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095881120300330

Similar Items

Anosmia-hyposmia and dysgeusia in COVID-19 may be due to SARS-CoV-2 protein mimicry of olfactory receptors
by: Robert Root-Bernstein
Published: (2020-09-01)

Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
by: Matt Lechner, et al.
Published: (2020-08-01)

Diagnosis of Anosmia and Hyposmia: A Systematic Review
by: Abdul K. Saltagi BS, et al.
Published: (2021-07-01)

Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia
by: Adrien A. Eshraghi, et al.
Published: (2020-09-01)

Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?
by: Syeda Anum Zahra, et al.
Published: (2020-11-01)

Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?
by: Noel Lorenzo Villalba, et al.
Published: (2020-04-01)

Anosmia – an independent predictor in the persistence of SARS-CoV-2 infection?
by: Stefan Lazar, et al.
Published: (2020-06-01)

The Lyon Clinical Olfactory Test: Validation and Measurement of Hyposmia and Anosmia in Healthy and Diseased Populations
by: Catherine Rouby, et al.
Published: (2011-01-01)

Anosmia – predictor independent în persistenţa infecţiei SARS-CoV-2?
by: Ştefan Lazăr, et al.
Published: (2020-06-01)

Anosmia/Hyposmia is a Good Predictor of Coronavirus Disease 2019 (COVID-19) Infection: A Meta-Analysis
by: Timotius Ivan Hariyanto, et al.
Published: (2021-01-01)

Anosmia and dysgeusia in COVID-19: A systematic review [version 1; peer review: 2 approved, 1 not approved]
by: Rodrigo M. Carrillo-Larco, et al.
Published: (2020-05-01)

Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis [version 1; peer review: 2 approved, 1 approved with reservations]
by: Endang Mutiawati, et al.
Published: (2021-01-01)

Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology
by: Stefano Pallanti
Published: (2020-07-01)

Telehealth in the times of SARS-CoV-2 infection for the otolaryngologist
by: Victoria W. Huang, et al.
Published: (2020-11-01)

Association of Anosmia and Positive SARS-CoV-2 (COVID-19) RT-PCR Test Results Among Patients in the Quezon City General Hospital
by: Jeff James Alega, et al.
Published: (2021-05-01)

Management of Dysgeusia related to Cancer
by: DURGESHWORI MUNANKARMI
Published: (2017-05-01)

Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD?
by: Sarah A. Imam, MD, et al.
Published: (2020-11-01)

Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms
by: Julien Brechbühl, et al.
Published: (2021-07-01)

Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection – A possible pattern? Observational study and review of the literature
by: Victoria Birlutiu, et al.
Published: (2021-06-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
by: Karima A. Al-Salihi, et al.
Published: (2021-01-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan
by: Wang-Huei Sheng, et al.
Published: (2021-01-01)

Unawareness of hyposmia in patients with idiopathic Parkinson’s disease
by: Utkarsh Patel, et al.
Published: (2020-01-01)

Hyposmia in geriatric depression can be a meningioma
by: Muruganandam Partheeban, et al.
Published: (2019-01-01)

Hypogeusia and hyposmia with topical 5-fluorouracil treatment
by: Auston Gillis, BS, et al.
Published: (2020-07-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour
by: Antczak, M., et al.
Published: (2021)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Association of Lower Socioeconomic Status and SARS-CoV-2 Positivity in Los Angeles, California
by: Lao-Tzu Allan-Blitz, et al.
Published: (2021-05-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Schrödinger’s Worker: Are They Positive or Negative for SARS-CoV-2?
by: Federico Meloni, et al.
Published: (2020-08-01)

The Epistemology of a Positive SARS-CoV-2 Test
by: Bandyopadhyay, P.S, et al.
Published: (2021)

NeoCoV Is Closer to MERS-CoV than SARS-CoV
by: Mohamed M Hassan, et al.
Published: (2020-06-01)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
by: Yetian Dong, et al.
Published: (2020-10-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
by: Wenhan Guo, et al.
Published: (2021-04-01)

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
by: Ritesh Gorkhali, et al.
Published: (2021-06-01)